Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
September 7th, 2022
Is There Still Hope For A Federal Privacy Bill This Year?
Privacy & Data Security Chair Daniel M. Goldberg shares his thoughts with Allison Schiff at AdExchanger about the American Data Privacy and Protection Act (ADPPA). Daniel says, “The legislature will need to go back to the drawing board on the issue of preemption. Many privacy advocates are concerned that the preemption language in the ADPPA undermines the privacy protections offered by comprehensive state privacy laws, including the California Consumer Privacy Act.”
Read Daniel’s full statement here.
Other Quoted
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
Global Brands Join Forces at Cannes to Champion Responsible Influencer Marketing
Hannah E. Taylor is quoted in the Wine Industry Network article covering the panel discussion, "#Ad to Impact: Embracing Responsibility, Empowering Creativity, Expanding Influence," held during Cannes Lions. Read more.
June 25 2026
